Coronavirus death toll hits 768,958 worldwide

WASHINGTON: The global pandemic COVID-19 has killed over 768,958 people worldwide and affected more than 21,613,699 people.

According to the latest data, the number of coronavirus infection cases across the world has surged to 21,613,699 and the pandemic has so far claimed 768,958 lives.

 Meanwhile, 14,328,729 patients have recovered from the pandemic so far. The coronavirus has infected 5,529,789 million people in the United States and caused 746 deaths during the last 24 hours.

 The total number of deaths from the COVID-19 in the United States has risen to 5,529,789. At least 3,317,832 COVID-19 cases have reported in Brazil with over 107,297 deaths.

Over 917,884 people have infected while 15,617 people died of the virus in Russia. The country has the third-highest number of recorded infections in the world.

India has reported 2,589,208 cases while 50,084 deaths due to the coronavirus. The United Kingdom has reported 41,361 fatalities and317,379 infections. Spain has recorded 28,617 fatalities and 358,843infections.

Peru has reported 525,803 cases while 26,075 deaths. In Chile, nearly 383,902 cases were confirmed, including more than 10,395 deaths.

Italy, which recorded its first coronavirus death at the end of February, has 35,392 fatalities, while 253,438 infections. Mexico has reported 56,543 deaths and 517,71 cases.

Meanwhile, the death toll is 19,492 in Iran as the confirmed number of cases is almost 341,070. Germany has reported 9,290 deaths and 224,478 infections. Turkey reported 248,117coronavirus cases and 5,955 fatalities.

France has reported 30,409 deaths and 215,521 cases. China has to date declared 4,634 deaths and 84,827 cases, with 79,575 recoveries and 618 active cases of the virus.

On Saturday, Russia had started manufacturing its new vaccine for COVID-19. Russia said that the vaccine had developed by Moscow’s Gamaleya Institute and the first for the coronavirus to go into production, will be rolled out by the end of this month.

The vaccine, called ‘Sputnik V’ in homage to the world’s first satellite launched by the Soviet Union in 1957, has yet to complete its final trials. The Russian vaccine’s approval comes before trials that would normally involve thousands of participants, commonly known as Phase III.

Such trials are usually considered essential precursors for a vaccine to secure regulatory approval. Russian President Vladimir Putin had said the vaccine, developed by Moscow’s Gamaleya Institute, was safe and that it had been administered to one of his daughters.

Health Minister Mikhail Murashko had earlier rejected safety concerns aired by some experts over Moscow’s rapid approval of the drug as groundless.